Association of Sarcopenic Obesity with the Risk of All-cause Mortality Among Adults over a Broad Range of Different Settings: a Updated Meta-analysis
Overview
Authors
Affiliations
Background: Previous cohort studies investigating the association between sarcopenic obesity (SO) and all-cause mortality among adult people have been inconsistent. We performed a meta-analysis to determine if SO is a predictor of all-cause mortality.
Methods: Prospective cohort studies that evaluated the association between SO and mortality in older people were identified via a systematic search of three electronic databases (PubMed, EMBASE, and the Cochrane Library). A random-effects model was applied to combine the results. We considered the methods recommeded by consensuses (dual X-ray absorptiometry,bio-impedancemetry, anthropometric measures or CT scan) to assess sarcopenic obesity.
Results: Of the 603 studies identified through the systematic review, 23 (Participants: 50866) were included in the meta-analysis. The mean age ranged from 50 to 82.5 years.SO was significantly associated with a higher risk of all-cause mortality among adult people (pooled HR = 1.21, 95% confidence interval [95% CI] = 1.10-1.32, p < 0.001, I = 64.3%). Furthermore, the subgroup analysis of participants showed that SO was associated with all-cause mortality (pooled HR = 1.14, 95% CI: 1.06-1.23) among community-dwelling adult people; similarly, this association was found in hospitalized patients (pooled HR = 1.65, 95% CI: 1.17-2.33). Moreover, the subgroup analysis demonstrated that SO was associated with all-cause mortality when using skeletal muscle mass (SMM) criteria, muscle strength criteria, and skeletal muscle index (SMI) criteria (HR = 1.12, 95% CI: 1.01-1.23; HR = 1.18, 95% CI: 1.05-1.33; and HR = 1.53, 95% CI: 1.13-2.07, respectively). In addition, we analyzed SO on the basis of obesity definition and demonstrated that participants with a SO diagnosis based on waist circumference (WC) (HR = 1.24, 95% CI: 1.09-1.40), body mass index (BMI) (HR = 1.29, 95% CI: 1.04-1.59), or visceral fat area (HR = 2.54, 95% CI: 1.83-3.53) have a significantly increase mortality risk compared with those without SO.
Conclusion: Based on our update of existing scientific researches, SO is a significant predictor of all-cause mortality among older people, particularly hospitalized patients. Therefore, it is important to diagnose SO and to treat the condition to reduce mortality rates among older people.
Sarcopenic Obesity: A Comprehensive Approach for Postmenopausal Women.
Park J, Chung Y, Song J, Kil K, Lee H, Chae J J Menopausal Med. 2025; 30(3):143-151.
PMID: 39829191 PMC: 11745730. DOI: 10.6118/jmm.24004.
Guandalini V, Tofani P, Souza Lima S, Coelho Silveira L, Cochar-Soares N, Barros Pereira da Silva T Aging Clin Exp Res. 2024; 36(1):222.
PMID: 39557762 PMC: 11573834. DOI: 10.1007/s40520-024-02866-9.
Acute Sarcopenia: Mechanisms and Management.
Damanti S, Senini E, De Lorenzo R, Merolla A, Santoro S, Festorazzi C Nutrients. 2024; 16(20).
PMID: 39458423 PMC: 11510680. DOI: 10.3390/nu16203428.
Reynolds 4th T, Mills N, Hoyte D, Ehnstrom K, Arata A Int J Mol Sci. 2024; 25(19).
PMID: 39408607 PMC: 11476861. DOI: 10.3390/ijms251910278.
Molina-Baena B, Alvarez-Bustos A, Antonio Carnicero J, Garcia-Garcia F, Rodriguez-Manas L Nutrients. 2024; 16(19).
PMID: 39408282 PMC: 11478913. DOI: 10.3390/nu16193315.